ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0091

Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic

Michael Lovy1, Norma Daniela Aguirre Vega1 and Crystal Escobar1, 1Desert Oasis Healthcare, Palm Springs, CA

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, Environmental factors, Fracture, Infection, Sjögren's Syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The most familiar presentation of pernicious anemia is an elderly Northern European woman with hematologic and neurologic manifestations.  More recently the influence of Helicobacter pylori (H. pylori), autoimmune polyendocrine syndromes (APS) and paraproteinemia on the development of pernicious anemia has been recognized.  The purpose of this study is to document the spectrum of pernicious anemia as manifest in a cohort of pernicious anemia patients diagnosed in a rheumatology clinic.

Methods: A retrospective chart review of the history and physical, laboratory and x-ray studies was conducted among patients diagnosed with pernicious anemia over a 10 year period.  Pernicious anemia was diagnosed on the basis of a low vitamin B12 level and either intrinsic factor or anti-parietal cell antibodies.

Results: A total of 150 patients, 106 females and 44 males ranging in age from 32-101 years (mean 71.8) were diagnosed with pernicious anemia.  Referral was based on acute fracture of the spine or pelvis-41,RA-30, arthritis-30, osteoporosis-16, pain-15, autoimmune disease-9, SLE-7, psoriasis-2.  There was a history of major osteoporotic fracture in 54, heartburn-73, past peptic ulcer disease-16, lower esophageal ring-3, thyroid disease-42, type 1 diabetes-13, and vitiligo-2.  12 patients were on proton pump inhibitors and 5 were on H-2 antagonists. The mean BMI was 27.3.  101 patients had a sensory deficit at the level of the ankle, including 38 with findings of a glove and stocking sensory loss.  Only 25 patients were anemic with 2 patients having a MCV >100 fL and 5 with a low serum iron.  Folic acid was < 8 ng/mL in 19 patients with a predominance of intrinsic factor over anti-parietal cell antibody present (p=0.039).  Vitamin D levels were < 12 ng/mL in 13.  H. pylori was diagnosed on the basis of a positive urea breath test in 21 patients at the time of initial evaluation (Group 1).  Paraproteinemia was identified with serum immunofixation in 19 (Group 2).  Autoimmune disease diagnosis (Group 3) included RA-32, SS-a or SS-b positive Sjogren's 9, SLE -3, psoriatic arthritis-4, CREST-2, spondyloarthropathy-2,inflammatory bowel disease-2, anti-PLA2R+ glomerulonephritis-1.  Patients with thyroid disease-42 constituted Group 4, with the remaining 51 in Group 5.  Mean age of the groups was 65.8, 77, 66, 71.3, and 71.7 respectively.  There was a statistically significant increase of autoimmune disease present in H. pylori + Group 1 compared to the remaining 129 patients without H. pylori (p=0.0295).  No other statistically significant differences were noted between Groups 1-5 or between intrinsic factor and anti-parietal cell antibody positive patients.

Conclusion: Pernicious anemia is most likely to be found among rheumatology patients with fracture, primary Sjogren’s ,thyroid disease, vitiligo and other features of APS as well as in patients with paraproteinemia.  Patients with autoimmune disease and those with H. pylori infection present with pernicious anemia at a younger age.  The statistically significant correlation among pernicious anemia patients between H. pylori infection and underlying autoimmune disease supports the hypothesis that H. pylori can act as a trigger of an autoimmune response in a genetically predisposed host.


Disclosure: M. Lovy, None; N. Aguirre Vega, None; C. Escobar, None.

To cite this abstract in AMA style:

Lovy M, Aguirre Vega N, Escobar C. Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/helicobacter-pylori-infection-autoimmune-disease-and-paraproteinemia-influence-the-presentation-of-a-cohort-of-150-pernicious-anemia-patients-diagnosed-in-a-rheumatology-clinic/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/helicobacter-pylori-infection-autoimmune-disease-and-paraproteinemia-influence-the-presentation-of-a-cohort-of-150-pernicious-anemia-patients-diagnosed-in-a-rheumatology-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology